Albuterol and Votrient drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Albuterol (albuterol) and Votrient (pazopanib hydrochloride). Common drug interactions include malaise among females and nausea among males.
The phase IV clinical study analyzes what interactions people have when they take Albuterol and Votrient. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.
What is Albuterol?
Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 161,052 Albuterol users. Check the latest studies of Albuterol.
What is Votrient?
Votrient has active ingredients of pazopanib hydrochloride. It is often used in metastatic renal cell carcinoma. eHealthMe is studying from 25,347 Votrient users. Check the latest studies of Votrient.
87 people who take Albuterol and Votrient together, and have interactions are studied.

What are the common drug interactions of Albuterol and Votrient, by gender? *:
female:
- Malaise (a feeling of general discomfort or uneasiness)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Pneumonia
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Sinusitis (inflammation of sinus)
- Vomiting
- Sedation
- Acute left ventricular failure (heart attack)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Aortic thrombosis (formation of a blood clot inside aorta)
male:
- Nausea (feeling of having an urge to vomit)
- Diarrhoea
- Flatulence (flatus expelled through the anus)
- Glossodynia (a burning or painful sensation in the tongue)
- Malignant neoplasm progression (cancer tumour came back)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Dehydration (dryness resulting from the removal of water)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Hypertension (high blood pressure)
- Back pain
What are the common drug interactions of Albuterol and Votrient, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Death
20-29:
- Death
- Hospitalisation
- Splenic haemorrhage (bleeding from spleen)
- Splenic vein thrombosis (blood clot in splenic vein)
30-39:
n/a
40-49:
- Death
- Oxygen saturation decreased
50-59:
- Chest pain
- Conduction disorder (serious disorder of the heart not responses proper to impulses)
- Diastolic dysfunction
- Dyspnoea (difficult or laboured respiration)
- Ejection fraction decreased (systolic heart failure)
- Fatigue (feeling of tiredness)
- Heart injury
- Left ventricular end-diastolic pressure increased
- Mitral valve incompetence (inefficient heart valve)
- Pulmonary embolism (blockage of the main artery of the lung)
60+:
- Death
- Fatigue (feeling of tiredness)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Gait disturbance
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Sinusitis (inflammation of sinus)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Vomiting
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Alanine aminotransferase increased
What are the existing conditions these people have? *
- Renal Cell Carcinoma (a kidney cancer): 45 people, 51.72%
- Neoplasm Malignant (cancer tumour): 8 people, 9.20%
- Metastases To Lung (cancer spreads to lung): 7 people, 8.05%
- Thyroid Cancer: 5 people, 5.75%
* Approximation only. Some reports may have incomplete information.
Do you take Albuterol and Votrient?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Albuterol and Votrient:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Albuterol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Votrient:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Albuterol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Votrient and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Costa DA, de Almeida SB, Barata PC, Quintela A, Cabral P, Afonso A, Silva JM, "Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach", Case Reports in Oncology, 2013 Jan .
- Costa DA, de Almeida SB, Barata PC, Quintela A, Cabral P, Afonso A, Silva JM, "Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach", Case Reports in Oncology, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on albuterol and pazopanib hydrochloride (the active ingredients of Albuterol and Votrient, respectively), and Albuterol and Votrient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Biotin cause Insomnia Exacerbated? - 22 seconds ago
- Drug interactions of Crestor and Mestinon - 27 seconds ago
- Drug interactions of Xtandi and Simvastatin - 34 seconds ago
- Could Theophylline cause Duodenal Ulcer Aggravated? - 36 seconds ago
- Could Ferrous Fumarate cause Keratitis? - 49 seconds ago
- Drug interactions of Remicade and Potassium - a minute ago
- Drug interactions of Klor-Con and Lipoic Acid - a minute ago
- Could Pantoprazole cause Oesophageal Spasm? - a minute ago
- Could Carboplatin cause Itching? - a minute ago
- Drug interactions of Linzess and Spiriva Respimat - a minute ago